Treatment of Postmenopausal Women with Osteoporosis at High Risk for Fracture:
Teriparatide (rDNA origin) injection is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopausal women with osteoporosis, teriparatide (rDNA origin) injection reduces the risk of vertebral and nonvertebral fractures.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
